Natural Product: NPC530848

Natural Product IDNPC530848
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
6"-cyano-6"-deoxy-TAN-1120
IUPAC Name (6~{a}~{S},8~{R},10~{S},10~{a}~{S})-8-[[(1~{S},3~{S})-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1~{H}-tetracen-1-yl]oxy]-2-(2-hydroxypropyl)-4,10-dimethyl-4,5,6,6~{a},7,8,10,10~{a}-octahydropyrano[3,4-d][1,3,6]dioxazocine-5-carbonitrile
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002106] Anthracyclines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey XMDNHTUCEGYMFQ-UWWRACIZSA-N
Standard InCHI InChI=1S/C35H40N2O12/c1-14(38)9-24-46-15(2)21(13-36)37-20-10-25(47-16(3)34(20)49-24)48-23-12-35(44,17(4)39)11-19-27(23)33(43)29-28(31(19)41)30(40)18-7-6-8-22(45-5)26(18)32(29)42/h6-8,14-16,20-21,23-25,34,37-38,41,43-44H,9-12H2,1-5H3/t14?,15?,16-,20-,21?,23-,24?,25-,34+,35-/m0/s1
SMILES COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]3C[C@@H]4NC(C#N)C(C)OC(CC(C)O)O[C@@H]4[C@H](C)O3)C(O)=C1C2=O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   680.26 Volume:   661.052
?
Van der Waals volume.
Dense:   1.029 LogP:   2.262
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.694
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.226
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   38.0
TPSA:   214.1
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   5.0 Rings:   6.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.236 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.495 Fsp3:   0.543
MCE-18:   144.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   1
Colloidal aggregators:   0.444 Fluc inhibitor:   0.002
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.273
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.612
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.017 Promiscuous compounds:   0.751

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.9 MDCK Permeability:   -5.189
Pgp-inhibitor:   0.081 Pgp-substrate:   0.826
PAMPA:   0.993
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.14
20% Bioavailability (F20%):   0.792 30% Bioavailability (F30%):   0.979
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.994
Plasma Protein Binding (PPB):   97.368% Volume Distribution (VD):   0.784
Fu: 2.606%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.319
OATP1B3 inhibitor:   0.867 BCRP inhibitor:   0.004
BSEP inhibitor:   0.978

ADMET: Metabolism

CYP1A2-inhibitor:   1.0 CYP1A2-substrate:   0.017
CYP2C19-inhibitor:   0.072 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.001 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.011
CYP3A4-inhibitor:   0.077 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.748
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  14.254 Half-life (T1/2):  3.85

ADMET: Toxicity

hERG Blockers:  0.048 hERG Blockers (10um):  0.301
Human Hepatotoxicity (H-HT):  0.96 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.997 Rat Oral Acute Toxicity:  0.986
Maximum Recommended Daily Dose:  0.999 Skin Sensitization:  0.995
Carcinogencity:  0.777 Eye Corrosion:  0.0
Eye Irritation:  0.003 Respiratory Toxicity:  1.0
Drug-induced Neurotoxicity:  0.371 Ototoxicity:  0.992
Hematotoxicity:  0.921 Drug-induced Nephrotoxicity:  0.877
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.883
A549 Cytotoxicity:  0.999 Hek293 Cytotoxicity:  0.96
BCF:   0.502
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.193
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.073
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.044
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO54638 Streptomyces sp. HS-NF-1006 Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC530848 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6882 Remote Similarity NPC109403
0.6809 Remote Similarity NPC487573
0.6327 Remote Similarity NPC261012
0.6327 Remote Similarity NPC314738
0.6263 Remote Similarity NPC468994
0.5918 Remote Similarity NPC603200
0.5825 Remote Similarity NPC600087
0.5743 Remote Similarity NPC601855
0.5579 Remote Similarity NPC611971

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC530848 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6882 Remote Similarity NPD6778 Phase 4
0.6809 Remote Similarity NPD6777 Approved
0.6327 Remote Similarity NPD6781 Phase 4
0.6327 Remote Similarity NPD6782 Phase 4
0.6286 Remote Similarity NPD7696 Phase 3
0.6286 Remote Similarity NPD7697 Phase 3
0.6286 Remote Similarity NPD7698 Approved
0.6263 Remote Similarity NPD6779 Approved
0.6263 Remote Similarity NPD6780 Approved
0.625 Remote Similarity NPD6776 Approved
0.619 Remote Similarity NPD7871 Phase 2
0.6132 Remote Similarity NPD7870 Phase 2
0.5579 Remote Similarity NPD6535 Phase 4
0.5556 Remote Similarity NPD8155 Clinical (unspecified phase)
0.5521 Remote Similarity NPD6534 Approved
0.5259 Remote Similarity NPD7701 Phase 2
0.5172 Remote Similarity NPD7801 Approved
0.5124 Remote Similarity NPD8058 Clinical (unspecified phase)
0.5124 Remote Similarity NPD8059 Phase 3
0.5088 Remote Similarity NPD7435 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data